These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1380 related items for PubMed ID: 23696034

  • 1. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG.
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M, Zhang XY, Yu X.
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [Abstract] [Full Text] [Related]

  • 3. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
    Yang Y, Liu Q, Li Z, Zhang R, Jia C, Yang Z, Zhao H, Ya S, Mao R, Ailijiang T, Bao Y, Zhang H.
    Carcinogenesis; 2018 Jul 03; 39(7):900-910. PubMed ID: 29365054
    [Abstract] [Full Text] [Related]

  • 4. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G, Fang J, Tong S, Qu L, Jiang H, Ding Q, Liu J.
    Prostate; 2015 Jun 15; 75(9):957-68. PubMed ID: 25728945
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling.
    Lee EK, Kim HJ, Lee KJ, Lee HJ, Lee JS, Kim DG, Hong SW, Yoon Y, Kim JS.
    Int J Oncol; 2011 Feb 15; 38(2):325-33. PubMed ID: 21132267
    [Abstract] [Full Text] [Related]

  • 6. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun BC.
    J Cell Mol Med; 2011 Mar 15; 15(3):691-700. PubMed ID: 20219012
    [Abstract] [Full Text] [Related]

  • 7. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
    Chung IH, Chen CY, Lin YH, Chi HC, Huang YH, Tai PJ, Liao CJ, Tsai CY, Lin SL, Wu MH, Chen CY, Lin KH.
    Oncotarget; 2015 Jun 20; 6(17):15050-64. PubMed ID: 25940797
    [Abstract] [Full Text] [Related]

  • 8. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
    Dong T, Zhang Y, Chen Y, Liu P, An T, Zhang J, Yang H, Zhu W, Yang X.
    Oncotarget; 2017 Jan 03; 8(1):1703-1713. PubMed ID: 27924058
    [Abstract] [Full Text] [Related]

  • 9. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tanaka S, Shiraha H, Nakanishi Y, Nishina S, Matsubara M, Horiguchi S, Takaoka N, Iwamuro M, Kataoka J, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Nouso K, Yagi T, Yamamoto K.
    Int J Cancer; 2012 Dec 01; 131(11):2537-46. PubMed ID: 22488108
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
    Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu JC.
    Hepatology; 2009 Nov 01; 50(5):1464-74. PubMed ID: 19821482
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lipocalin-2 induces apoptosis in human hepatocellular carcinoma cells through activation of mitochondria pathways.
    Chien MH, Ying TH, Yang SF, Yu JK, Hsu CW, Hsieh SC, Hsieh YH.
    Cell Biochem Biophys; 2012 Dec 01; 64(3):177-86. PubMed ID: 22707293
    [Abstract] [Full Text] [Related]

  • 16. Prp19 facilitates invasion of hepatocellular carcinoma via p38 mitogen-activated protein kinase/twist1 pathway.
    Yin J, Wang L, Zhu JM, Yu Q, Xue RY, Fang Y, Zhang YA, Chen YJ, Liu TT, Dong L, Shen XZ.
    Oncotarget; 2016 Apr 19; 7(16):21939-51. PubMed ID: 26959880
    [Abstract] [Full Text] [Related]

  • 17. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C, Guo F, Xu G, Ma J, Shao F.
    Oncol Rep; 2015 Apr 19; 33(4):1872-82. PubMed ID: 25653024
    [Abstract] [Full Text] [Related]

  • 18. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J, Yuan W, Wu L, Tang Q, Xia Q, Ji J, Liu Z, Ma Z, Zhou Z, Cheng Y, Shu X.
    Oncotarget; 2017 Feb 07; 8(6):9961-9973. PubMed ID: 28035069
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma.
    Wang Y, Sun B, Zhao X, Zhao N, Sun R, Zhu D, Zhang Y, Li Y, Gu Q, Dong X, Wang M, An J.
    Oncotarget; 2016 Apr 26; 7(17):24383-401. PubMed ID: 27027434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.